HFE and hepatocellular carcinoma: Pirisi et al. found that in hepatocellular carcinoma, patients with WT HFE live longer than those with HFE polymorphisms [27] and Gannon et al. reported that patients with C282Y HFE polymorphism in epithelial ovarian cancer had decreased overall survival compared to patients with WT HFE [28].